Global /India /Healthcare /Drug Manufacturers - General /506128
chevron_leftBack
Parnax Lab Ltd. logo

Parnax Lab Ltd.

506128
BSE: 506128 Delayed
164.90INR 1.7%
1.75 USD
As of 20 June 2026, Parnax Lab Ltd. has a market cap of $20.07M USD, ranking #37057 globally and #2657 in India. It ranks #3330 in the Healthcare sector, and #1111 in the Drug Manufacturers - General industry.
Global Rank
37057
Country Rank
2657
Sector Rank
3330
Industry Rank
1111
Key Stats
Market Cap
$20.07MUSD
1.89B INR
Enterprise Value
$27.16MUSD
2.56B INR
Revenue (TTM)
$24.16MUSD
2.28B INR
EBITDA (TTM)
$2.92MUSD
276.08M INR
Net Income (TTM)
$1.33MUSD
125.2M INR
EBITDA Margin
12%
Profit Margin
5.5%
PE Ratio
15.1
PS Ratio
0.8
PB Ratio
2.1
EV/EBITDA
9.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mihir Shah open_in_new
Employees
12
Founded
1982
Website
naxparlab.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1.7% 4% 22% 40% 25% 65%

News

Loading...

Markets

Exchange Ticker Price
Bombay Stock Exchange
MIC: XBOM
PRIMARY
506128 (PARNAXLAB)
Parnax Lab Ltd
ISIN: INE383L01019
Shares Out.:
11.486M1
TV:
SA:
YF:
GF:
BA:
MS:
164.90 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Parnax Lab Ltd.

Parnax Lab Limited engages in the manufacture and export of pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; cosmetic products; herbal products; and nutraceutical products. It also provides Oral Formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, formulations for geriatrics, highly viscous products, and suspensions. In addition, the company provides drug identification and development services; in- and out-licensing services; and contract research and manufacturing services The company was formerly known as Krishna-Deep Trade & Investments Limited and changed its name to Parnax Lab Limited in April 2012. The company was incorporated in 1982 and is headquartered in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
225K%
39.1
DIVISLAB
$18.38B
1.73T INR
91K%
70.0
$15.17B
1.43T INR
75K%
63.0
$11.73B
1.11T INR
58K%
19.6
MANKIND
$9.87B
931.67B INR
49K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
48K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
4M%
38.1
JNJ
$547.28B
3M%
26.4
ABBV
$360.63B
2M%
97.4
$318.3B
256.25B CHF
2M%
19.9
AZN
$284.64B
215.59B GBP
1M%
27.6
MRK
$274.03B
1M%
15.1
chevron_leftBack